The Covid-19 vaccine maker said the BioNtrainer is expected to arrive in Kigali, Rwanda in the first quarter of 2023.
In February, the company planned to develop a vaccine factory using shipping containers and send it to Africa as assembly kits to ease what the World Health Organization has described as huge disparities in global Covid-19 vaccine access.
BioNtech said the facility at Kigali will house the first BioNtrainer, which is expected to become part of a wider supply network spanning several African nations that will have access to the mRNA-based vaccine.
Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.
Go to: https://www.reuters.com/
